| A |
|
| Acetyl.l.carnitine for
dementia |
| A.G.E. dementia care
program |
| Aluminium exposure and
dementia |
| Alzheimer's disease. See Dementia |
| Anorexia nervosa |
|
drug therapy |
|
family therapy |
|
monitoring of food
intake |
|
psychoeducation |
| Antidepressant-benzodiazepine,
treatment for major depression |
| Antidepressants, for
bipolar disorder |
| Anti-parkinsonism
drugs, for tardive dyskinesia |
| Anxiety |
|
See also specific conditions |
|
alternative
therapies |
|
care and support |
|
counselling |
|
creative therapy |
|
pharmacotherapy |
|
psychotherapy |
| Assertive Community Treatment |
|
for patients with
schizophrenia |
|
Top |
| B |
|
| Behaviour therapy |
|
for dementia |
|
for personality
disorders |
| Benzodiazepines |
|
for anxiety |
|
for tardive dyskinesia |
| Beta-blockers, as
adjuncts to neuroleptics for schizophrenia |
| Bipolar Disorder |
|
care and support |
|
electroconvulsive
therapy (ECT) |
|
genetic counselling |
|
maintenance therapy |
|
non-compliance with
drug therapy |
|
pharmacotherapy |
|
|
acute depression |
|
|
acute mania |
|
|
antidepressants |
|
|
maintenance therapy |
|
|
mood stabilisers |
|
|
neuroleptics |
|
|
suicide rates |
|
psychotherapy |
| Bulimia nervosa |
|
antidepressant and
cognitive behavioural therapy |
|
cognitive behavioural
therapy |
|
dietary education |
|
exposure and response
prevention |
|
group therapies |
|
monitoring of food
intake |
|
pharmacotherapy |
|
psychotherapy |
|
Top |
| C |
|
| Carbamazepine |
|
for bipolar disorder |
|
|
acute depression |
|
|
mood stabilisers |
|
for personality
disorders |
| Care and support, |
|
for bipolar disorder |
|
for dementia |
|
|
24 hr support services |
|
|
A.G.E. dementia care program |
|
|
formal care planning |
|
for schizophrenia |
| Carers, of patients
with dementia |
| Case management, for
schizophrenia |
| Cerultide, for tardive
dyskinesia |
| Chlorpromazine |
|
for schizophrenia |
|
|
high maintenance doses |
|
|
rehabilitation and continuing care |
| Clozapine, for
schizophrenia |
| Cognitive behavioural
techniques, for schizophrenia |
| Cognitive Behavioural
Therapy, for bulimia nervosa |
| Community Mental Health Team (CMHT) management, |
|
for personality
disorders |
|
for schizophrenia |
| Counselling |
|
for anxiety |
|
for depression in primary care settings, |
|
|
efficacy of counselling |
|
|
specific therapeutic model |
| Creative therapy, for
anxiety |
|
Top |
| D |
| Delirium |
|
early diagnosis |
|
environment,
normalisation of |
|
multidisciplinary
assessment |
|
prescribing practices |
|
|
prevention and promotion |
|
|
treatment and care |
|
prevention, in
surgical patients |
|
prognosis |
|
recognition in primary
care |
|
treatment of
underlying medical problems |
| Dementia |
|
A.G.E dementia care
program |
|
Abnormal clock drawing
to distinguish Alzheimer's from other dementias |
|
genetic counselling |
|
hormone replacement
therapy |
|
mental state tests |
|
pharmacotherapy |
|
|
specific drug therapies |
|
|
treatment and care |
|
physical restraints |
|
prognosis |
|
public education |
|
reversible |
|
risk factors for
vascular dementia |
|
support Top |
| Depression, major |
|
acute phase |
|
combining
antidepressants and psychotherapy |
|
continuation and
maintenance therapy |
|
electroconvulsive
therapy (ECT) |
|
|
antidepressant drug treatment
versus electroconvulsive therapy (ECT) |
|
|
bilateral ECT |
|
|
general statements |
|
identification |
|
identification |
|
in older people |
|
in older people |
|
in primary care
settings |
|
pharmacotherapy |
|
|
antidepressants |
|
|
reduction in drop-outs |
|
|
St John's wort (hypericum) |
|
|
treatment of dysthymia |
|
psychotherapy |
|
|
psychotherapy for major
depression |
|
|
trial of psychotherapy |
|
suicide rates |
| Donepezil, for
dementia |
| Dysthymia |
|
Top |
| E |
| Eating Disorders
see also specific conditions |
| Education and training for patients |
|
with anxiety |
|
with dementia |
| Electroconvulsive therapy (ECT) |
|
for bipolar disorder |
|
for major depression
|
|
|
antidepressant drug treatment
versus electroconvulsive therapy (ECT) |
|
|
bilateral ECT |
|
|
general statements |
|
for schizophrenia |
| Essential fatty acids,
for tardive dyskinesia |
| Estrogen, for tardive
dyskinesia |
| Exposure and response
prevention, for bulimia nervosa |
|
|
F |
|
| Family intervention,
for patients with schizophrenia |
| Family therapy, for
patients with anorexia |
| Fluoxetine, |
|
for patients with
anorexia |
|
for patients with
bulimia nervosa |
| Formal care planning,
for patients with dementia |
| Top |
G |
|
| Genetic counselling |
|
for bipolar disorder |
|
for dementia |
|
for schizophrenia |
| Glycosaminoglycan, for
dementia |
| Group therapies, for
bulimia nervosa |
|
H |
|
| Haloperidol, |
|
for acute treatment of
schizophrenia |
|
for schizophrenia |
| Hormone replacement
therapy and dementia |
| Huntington’s
Disease |
| Hydergine, for
dementia |
| Hypericum,
for depression |
|
I |
|
| Insulin, for tardive
dyskinesia |
| Top |
L |
|
| Life skills programmes
for chronic mental illness |
| Lithium |
|
for bipolar disorder |
|
|
acute mania |
|
|
acute depression |
|
for tardive dyskinesia |
| Living environment,
for patients with dementia |
|
M |
|
| Mental state tests,
for dementia |
| Monoamine oxidase
inhibitors (MAOIs), for personality disorders |
| Multidisciplinary assessment & care |
|
of anxiety |
|
of delirium |
|
of dementia |
|
of eating disorders |
|
of schizophrenia |
|
Top |
N |
|
| Neuroleptics |
|
cessation or reduction
for tardive dyskinesia |
|
for bipolar disorder |
|
for dementia |
|
for personality
disorders |
|
for schizophrenia |
|
|
low-dose neuroleptic therapy |
|
|
neuroleptic cessation or reduction |
|
|
neuroleptic-induced tardive
dyskinesia |
|
|
resistant to typical neuroleptics |
|
|
treatment and care |
| Nicergoline, for
dementia |
| Nimodipine, for
dementia |
| Non-NHS
professional groups and agencies |
|
for dementia |
|
|
O |
|
| Obsessive compulsive
disorder (OCD) |
|
see also anxiety |
|
psychosurgery |
|
self help groups |
| Olanzapine, for
schizophrenia |
| Top |
| P |
| Parenting |
| Personality
disorders |
|
assessment |
|
behaviour therapy |
|
classification and
diagnosis |
|
Community Mental
Health Team (CMHT) management |
|
pharmacotherapy |
|
prevention and
promotion |
|
rehabilitation and
continuing care |
|
therapeutic community
treatment |
|
treatment and care |
| Physical restraints,
for patients with dementia |
| Piracetam, for
dementia |
| Psychosurgery for
obsessive compulsive disorder |
| Psychotherapy |
|
for anxiety |
|
for bipolar disorder |
|
for bulimia nervosa |
|
for dementia |
|
for major depression |
|
|
efficacy for acute treatment |
|
|
general statements |
|
|
treatment for major depression |
|
for schizophrenia |
| Public education |
|
about dementia |
|
to reduce the stigma
of schizophrenia |
|
Top |
| R |
| Reality orientation
for patients with dementia |
| Respite care, for
patients with dementia |
| Risperidone, for
schizophrenia |
|
|
| S |
| Schizophrenia |
|
Assertive Community
Treatment |
|
care and support |
|
case management |
|
cognitive behavioural
techniques |
|
Community Mental
Health Team (CMHT) management |
|
depot medication for
maintenance |
|
electroconvulsive
therapy (ECT) |
|
family intervention |
|
genetic counselling |
|
pharmacotherapy |
|
|
beta-blockers |
|
|
chlorpromazine |
|
|
conventional antipsychotic agents |
|
|
low-dose neuroleptic therapy |
|
|
treatment and care |
|
relapse |
|
resistance to
neuroleptics |
|
short stay policy |
|
social skills training |
|
tardive dyskinesia |
|
treating hearing
impairment in the elderlyTop |
| Selective serotonin reuptake inhibitors (SSRIs) |
|
in major depression |
|
|
Cochrane reviews |
|
|
depression in primary care
settings |
|
|
drop-outs |
| Selegiline, for
dementia |
| Self help groups, for
obsessive compulsive disorder |
| Social services, See Non-NHS professional groups and agencies |
| Social skills
training, for schizophrenia |
| Sodium valproate |
|
for bipolar disorder |
|
|
pharmacotherapy: acute
depression |
|
|
pharmacotherapy: acute mania |
| St. John's wort. See Hypericum |
| Substance misuse, link
with bipolar disorder |
| Suicide |
| Suicide rates in
people with major depression |
|
Top |
| T |
| Tacrine, for dementia |
| Tardive dyskinesia |
|
efficacy of
benzodiazepine drugs and cholinergic medications |
| Tetrabenzene, for
tardive dyskinesia |
| Therapeutic community treatment |
|
for personality
disorders |
| Tricyclics (TCAs), for major depression |
|
antidepressants |
|
drop-outs |
|
| V |
| Validation therapy for
patients with dementia |
| Vitamin E, for tardive
dyskinesia |
| Vocational
rehabilitation, for schizophrenia |
|
| Z |
|
| Zuclopenthixol
acetate, for schizophrenia |
